#Weight Management

Hundreds of English Children Prescribed Weight-Loss Jabs, Figures Show

Hundreds of English Children Prescribed Weight-Loss Jabs, Figures Show

Hundreds of children in England are receiving prescriptions for GLP-1 medications, including some under 12, according to a Guardian investigation of NHS prescribing data. In the 2025-26 financial year, 419 prescriptions were issued to under-18s, 10 of them to children under 12. Experts say the figures likely understate the true total, and they stress that children who start these drugs need specialist supervision and long-term monitoring. The findings come as childhood obesity rates continue to rise and as new global guidance advises against giving obesity medications to children under 10.

Why Community Pharmacies May Be the Key to Staying on GLP-1 Medications

Why Community Pharmacies May Be the Key to Staying on GLP-1 Medications

A new Milken Institute report, released alongside survey research, argues that community pharmacies can play a central role in helping patients stay on GLP-1 medications. Real-world data cited in the report indicates that roughly 47% to 68% of people stop treatment within the first year, and nearly three in four GLP-1 users say more time with a pharmacist would improve their experience and results. The report points to side effects during dose changes, prior authorization hurdles, and out-of-pocket costs as common reasons patients abandon therapy. It also highlights pharmacy-led check-ins, navigation support, and clearer reimbursement pathways as practical steps that could help patients and pharmacy teams stay on track over the long term.